Nebivolol, carvedilol and metoprolol do not influence cardiac Ca 2+ sensitivity

Author： Bundkirchen A.   Brixius K.   Bolck B.   Mehlhorn U.   Bloch W.   Schwinger R.H.G.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.422, Iss.1, 2001-06, pp. : 175-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of gender on the sensitivity of rat cardiac muscle to extracellular Ca 2+

By Wang S.-N.   Wyeth R.P.   Kennedy R.H.  

European Journal of Pharmacology, Vol. 361, Iss. 1, 1998-11 ,pp. : 73-77

Elsevier

Access to resources Recommend Favorite

Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol

By  

Current Drug Metabolism, Vol. 17, Iss. 1, 2016-01 ,pp. : 30-36

Bentham Science Publishers

Access to resources Recommend Favorite

Carvedilol superior to nebivolol for HF due to cardiomyopathy

By  

Inpharma, Vol. 1, Iss. 1519, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Carvedilol ices metoprolol tartrate in chronic heart failure

By  

Inpharma, Vol. 1, Iss. 1485, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Carvedilol less costly than metoprolol in patients with HF

By  

Inpharma, Vol. 1, Iss. 1335, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite